Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial

Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T04:45:59.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T06:38:55.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A 403 Forbidden message appears where the clinical study record would normally be displayed, so the study details are unavailable.
    Difference
    0.5%
    Check dated 2026-10-04T08:15:45.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now shown for the study record, indicating that access to the page is blocked.
    Difference
    18%
    Check dated 2026-09-20T02:40:49.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a minor metadata update to the ClinicalTrials.gov entry. This change represents a version bump rather than a modification to the study content or data.
    Difference
    0.0%
    Check dated 2026-08-29T23:50:51.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page revision number was updated from v3.6.4 to v3.6.5, indicating a small backend update to the record. This does not alter study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-08T23:04:32.000Z thumbnail image

Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.